- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06024850
Predictive Factors of Good Results After Multiligamentar Knee Reconstruction (MLKR)
Study Overview
Detailed Description
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Thomas NERI, MD PhD
- Phone Number: +33 (0)477127549
- Email: Thomas.Neri@chu-st-etienne.fr
Study Contact Backup
- Name: Pierre-Henri VERMOREL, resident
- Phone Number: +33 (0)477127549
- Email: vermoph@hotmail.fr
Study Locations
-
-
-
Saint-Étienne, France
- Recruiting
- CHU Saint-étienne
-
Principal Investigator:
- Thomas NERI, MD PhD
-
Sub-Investigator:
- Pierre-Henri VERMOREL, resident
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Any patient who benefits of a multiligamentar knee reconstruction at hospital of Saint-Etienne
Exclusion Criteria:
- Refusal
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
multiligamentar knee reconstruction
Any patient who benefits of a multiligamentar knee reconstruction at hospital of Saint-Etienne will be included. Datas collected by medical record. |
Datas collected by medical record: medical data (weight, height, smoking status, history) and socio-demographic data (age, occupation, type of injury) information, assessment of knee function before surgery, at 6 months and 1 year after surgery, magnetic resonance imaging (MRI) and radiological imaging at 1 year after surgery, results of the Iso-kinetic Muscle Assessment Test at 1 year after surgery to objectively determine the recovery of muscle function The data collected will be used to perform a statistical analysis to evaluate the factors predicting a good long-term post-surgical evolution |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Functional score : International Knee Documentation Committee (IKDC)
Time Frame: Months : 0, 6 and 12
|
The International Knee Documentation Committee (IKDC) is a questionnaire that assigns patients an overall functional score.
Three categories are examined by the questionnaire: symptoms, sports activity and knee function, on a scale of 0 to 100.
|
Months : 0, 6 and 12
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Functional score : Knee Injury and Osteoarthritis Outcome Score (KOOS)
Time Frame: Months : 0, 6 and 12
|
The Knee Injury and Osteoarthritis Outcome Score (KOOS) is used to assess immediate and long-term patient outcomes after knee injury.
Five outcomes are assessed by the self-administered KOOS: pain, symptoms, activities of daily living, sport and recreation function, and knee-related quality of life, on a scale of 0 to 100.
|
Months : 0, 6 and 12
|
|
Visual Analogue Scale (VAS) scale
Time Frame: Months: 0, 6 and 12
|
Analysis of the Visual Analogue Scale (VAS) scale (from 0 to 10, 10 = pain ++)
|
Months: 0, 6 and 12
|
|
Laxity
Time Frame: Month : 12
|
Laxity assessed by Magnetic Resonance Imaging (MRI)
|
Month : 12
|
|
Joint amplitudes
Time Frame: Months: 0, 6 and 12
|
Joint amplitudes assessed by the iso-cinetic test
|
Months: 0, 6 and 12
|
|
Clinical data
Time Frame: Month : 0
|
Data collected at inclusion
|
Month : 0
|
|
Recovery of muscle function
Time Frame: Month : 12
|
Recovery of muscle function measured by iso kinetic muscle assessment
|
Month : 12
|
Collaborators and Investigators
Investigators
- Principal Investigator: Thomas NERI, MD PhD, CHU Saint-étienne
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IRBN342022/CHUSTE
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.